Riverbridge Partners’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97.4M Sell
183,941
-53,466
-23% -$24.7M 2.72% 7
2026
Q1
$114M Sell
237,407
-35,562
-13% -$18.2M 2.79% 8
2025
Q4
$153M Sell
272,969
-92,119
-25% -$52.3M 2.87% 6
2025
Q3
$188M Sell
365,088
-68,936
-16% -$30.1M 3.17% 5
2025
Q2
$136M Sell
434,024
-47,102
-10% -$14.1M 2.19% 9
2025
Q1
$147M Sell
481,126
-36,407
-7% -$12.2M 2.35% 8
2024
Q4
$172M Sell
517,533
-34,111
-6% -$11.6M 2.35% 9
2024
Q3
$184M Buy
551,644
+15,648
+3% +$5.94M 2.46% 8
2024
Q2
$221M Sell
535,996
-70,254
-12% -$27.8M 3% 7
2024
Q1
$245M Sell
606,250
-77,693
-11% -$27.3M 2.99% 4
2023
Q4
$210M Buy
683,943
+43,036
+7% +$11.6M 2.62% 7
2023
Q3
$155M Sell
640,907
-10,799
-2% -$2.76M 2.12% 13
2023
Q2
$157M Buy
651,706
+211,011
+48% +$43.8M 1.97% 16
2023
Q1
$82.9M Sell
440,695
-14,999
-3% -$3.1M 1.16% 31
2022
Q4
$96.8M Sell
455,694
-11,143
-2% -$2.23M 1.45% 22
2022
Q3
$73.4M Buy
466,837
+29,134
+7% +$4.65M 1.09% 28
2022
Q2
$65.5M Buy
437,703
+103,524
+31% +$15M 1.05% 33
2022
Q1
$54.7M Buy
334,179
+30,158
+10% +$4.97M 0.62% 59
2021
Q4
$66.2M Buy
304,021
+11,340
+4% +$2.37M 0.65% 52
2021
Q3
$55.4M Sell
292,681
-3,459
-1% -$631K 0.56% 65
2021
Q2
$52.3M Buy
296,140
+13,429
+5% +$2.32M 0.53% 67
2021
Q1
$46.4M Buy
+282,711
New +$43.2M 0.53% 64

Other funds holding MEDP

Riverbridge Partners's MEDP Position: Q2 2026 in Review

Riverbridge Partners reduced its Medpace (MEDP) stake by 23% in Q2 2026, selling an estimated $24.7M and leaving 183,941 shares worth $97.4M. The position accounts for 2.72% of the portfolio, ranked #7.

Riverbridge Partners first reported a position in MEDP in Q1 2021 and has held it in 22 quarters since. The position peaked at $245M in Q1 2024. 72 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Riverbridge Partners held 183,941 shares of Medpace worth $97.4M as of Q2 2026.
  • Riverbridge Partners sold 53,466 Medpace shares in Q2 2026, an estimated $24.7M.
  • Medpace made up 2.72% of Riverbridge Partners's portfolio in Q2 2026, its #7 holding.
  • Riverbridge Partners first reported a position in Medpace in Q1 2021 and has held it in 22 quarters since.
  • Riverbridge Partners's Medpace position peaked at $245M in Q1 2024.
  • 72 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Riverbridge Partners's 13F filing for Q2 2026, filed 13 Jul 2026.